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Abstract 
 
Background: The aim was to compare the efficacy and acceptability of two Internet-based 
fertility awareness based methods of family planning (FABM). 
Study Design: Six hundred and sixty-seven women and their male partners were randomized 
into either an electronic hormonal fertility monitor (EHFM) group or a cervical mucus 
monitoring (CMM) group.  Both groups utilized a web site with instructions, charts, and support.  
Acceptability was assessed online at 1, 3, and 6 months. Pregnancy rates were determined by 
survival analysis.  
Results:  The EHFM participants (N=197) had a total pregnancy rate of 7 per 100 users over 12 
months of use compared with 18.5 for the CMM group (N=160).  The log rank survival test 
showed a significant difference (p < .01) in survival functions.   Mean acceptability for both 
groups increased significantly over time (p < .0001).  Continuation rates at 12 months for the 
monitor group were 40.6% and the mucus group 36.6%.     
Conclusion: In comparison with the CMM, the EHFM method of family planning was more 
effective. All users had an increase in acceptability over time.  Results are tempered by the high 
drop-out rate.   
Keywords: fertility awareness based methods; natural family planning; family planning; fertility 
monitoring     
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1. Introduction 
 Unintended pregnancies are a major health problem for women in developed and 
developing countries [1-3].  Many of these unintended pregnancies are due to discontinuation of 
contraceptive methods and, in turn, discontinuation is often due to side effects [2,4].  On the 
other hand, fertility awareness based methods of family planning (FABM) are free of side 
effects, have comparable continuation rates due to dissatisfaction [2], and are accepted by many 
cultures and religions [5]. 
 However, based on the 2006 National Survey of Family Growth, only about 0.1% of 
women in their reproductive years currently use modern FABM [6,7].   Major reasons why so 
few couples use FABM are: 1) they are ineffective; 2) they are not easy to provide or use; 3) 
health professionals are reluctant to provide FABM services, and users struggle with the periodic 
abstinence and anxiety over unintended pregnancy [8-12].  Although FABM, as it presently 
stands, has its drawbacks, there are many advantages as well.  If the drawbacks to the use of 
FABM can be reduced, then these methods could become a realistic and relatively inexpensive 
way of increasing the proportion of pregnancies that are intended, as well as improving health 
outcomes, especially among women of reproductive age using no method of family planning 
and/or the self-devised rhythm method [7]. 
 Researchers at Marquette University developed a new FABM system based on hormonal 
monitoring technology and conducted a number of cohort efficacy studies of the system [13-15]. 
They also simplified the system so that it could be initially taught in a 10-12 min office session 
[10,16]. The method uses either cervical mucus or an electronic hormonal fertility monitor (or 
both) and a calendar-based formula as a double check for the beginning and end of the fertile 
phase.  Whether the woman user observes cervical mucus or uses the electronic hormonal 
fertility monitor (EHFM), she rates her fertility as being low, high, or peak, and utilizes the same 
calendar-based formula for a double check.   
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 Researchers also developed an online system to teach couples to use the new FABM [16].  
It was determined that an online service system for FABM would be more efficient in being able 
to reach people around the country and world.  The online site (http://nfpstudy.marquette.edu) 
has free information on FABM, downloadable charting systems, access to protocols for special 
circumstances (e.g., using FABM while breastfeeding), and instructions for achieving and 
avoiding pregnancy. The web site includes a one-page Quick Start instruction that can be read in 
5 min and allows the user to begin charting and using FABM immediately.  In addition, couples 
are able to access an electronic charting system, discussion forums, and receive consultation 
from health professionals with expertise in the use of FABM.   The online charting system also 
notifies the user of possible health problems, including unusual bleeding, infertility, and cycle 
dynamics that are out of the norm.   
 Although a pilot efficacy study was conducted with this online FABM system, the pilot 
site gave the woman user the choice of using the EHFM, cervical mucus monitoring (CMM), or 
both [16].  There is a need for randomized comparisons of FABM to determine which are more 
effective and easy to use.  Therefore, the purpose of the current study was to compare the 
efficacy and acceptability of two Internet-supported FABM (i.e., EHFM with traditional CMM) 
in aiding couples to avoid pregnancy.  Since CMM is often confusing and subjective, we 
hypothesized that there would be more acceptability and fewer unintended pregnancies with 
EHFM.   
 
 
2. Methods 
  This was a 12-month (13 cycles) prospective randomized clinical efficacy trial of the 
EHFM plus fertility algorithm NFP method in comparison with the CMM plus algorithm FABM.  
Six hundred sixty-seven couples seeking to avoid pregnancy with NFP were randomized into 
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either an EHFM group (N=337) or a CMM only group (N=330) (see Fig. 1).  All couple 
participants (men and women) were assessed as to their perceived “acceptability and ease of use” 
with the online FABM system at 1, 3, and 6 months of use.   
 In order to achieve 80% power with a total unintended pregnancy rate of 10% for the EHFM 
group and a 20% pregnancy rate for the CMM group, a total sample size of 600 participants (300 
per group) was pre-determined.  An additional 150 couples were proposed as an over sample and 
to ensure that enough participants will complete the study, i.e., 75 participants for each group.  
The over sampling of 150 participants is based upon the typical discontinuation rate for modern 
FABM of approximately 25%.  Randomization took place automatically by computer generation 
when couples registered online and consented to participate.  All couples received a free EHFM 
but those in the CMM group received the monitor only after completing 12 months of CMM 
online charting.  All couples received $10 for each menstrual cycle chart completed.  This study 
received IRB approval through the university Office of Research Compliance. 
 The inclusion criteria for the female partners of the couple participants were that they 
needed to be  between the age of 18 and 42 years, have a stated menstrual cycle range of 21-42 
days, have no history of hormonal contraceptives for the past 3 months and if post breastfeeding, 
have experienced at least 3 cycles past weaning.  Male partners were to have no known fertility 
problem and be between the ages of 18 and 50 years.  Six hundred sixty-seven couple 
participants were recruited (from April, 2008 through December, 2010) by online search engine 
ads, e-mail list serves, and by word of mouth through fertility blogs and social networking sites.  
Of the 667 participants who registered, 346 contributed online charting.  All potential 
participants were contacted at least every 3 months by e-mail and encouraged to complete the 
study and contribute online charts.  
 All participants received online instructions with an audio slide show that lasted 12-13 min 
and completed a 10-item quiz to measure their understanding.  Participants in the EHFM group 
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received a Clearblue Easy Fertility Monitor (CBFM), which is designed to detect the rising level 
of urinary estrone-3-gluconuride (E3G) and the surge in urinary LH.  The CBFM is based on 
urinary hormonal immunoassay techniques.  Product testing has shown the Clearblue monitor to 
be 98.8% accurate in detecting the LH surge [17,18].  The CBFM is initiated when the user 
pushes a button on the monitor labeled “M” on the first day of her period.  The monitor then 
indicates which day of the cycle the user is on.  The monitor requests either 10 or 20 daily urine 
tests per cycle.  When the monitor requests a test, the user places the test strip under her urine 
stream for 3s.  The test strip is then placed in the monitor and read.  The monitor will show a 
fertility status of “low”, “high” or “peak”.  Participants were asked to record on an electronic 
fertility chart their fertility status (low, high or peak) and any intercourse that occurred on a daily 
basis as well as their menstrual bleeding.   
Women who were in the CMM group were asked to observe for cervical mucus on a 
daily basis and to chart the highest level observed.  They were instructed to “think. look, check, 
and chart” the cervical mucus, i.e., to think about how the mucus feels all through the day, to 
look at the mucus when going to the bathroom and before bedtime, to check  mucus every day, 
and to chart the most fertile mucus sign at end of day.  Written, oral, and visual descriptions 
(pictures) of the three levels of cervical mucus were provided online to the CMM users. These 
are similar procedures used with other CMM and with the World Health Organization [WHO] 
multi-site, multi-country study of the ovulation method (OM) [19].    
All participants used the online electronic charting system which has designated sections 
for recording the results of CMM and the EHFM – as either L = low, H = high, or P = peak.  The 
charting system provides a pop-up window for the user that illustrates the three levels of cervical 
mucus and the three levels provided by the fertility monitor.  The charting automatically 
indicates (in light blue) the fertile phase (based on the algorithm) as the user charts.  The 
electronic charting system automatically notifies the user of the possibility of a pregnancy when 
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the luteal phase goes beyond 19 days.  The charting system then prompts the user to take a 
pregnancy test and complete an online pregnancy evaluation.  The online charting system also 
cues the woman user to a link that launches a pregnancy evaluation form on each menstrual cycle 
that is charted.   
 All participants were instructed to not have intercourse or genital contact during the 
fertile window – i.e., from the first day of fertility through the last day of fertility.  They were 
also informed to refrain from intercourse on all "high" and "peak" days and to use the following 
instructions for determining the fertile window: fertility begins on day 6 for the first 6 cycles and 
ends three days past the last peak day (of either mucus or monitor).  After 6 cycles of use, 
fertility begins on the earliest day of peak during the last 6 cycles minus 6 days.  Fertility ends on 
the last peak day of the last 6 cycles plus 3 full days.   
Three professional nurse FABM teachers evaluated all pregnancies that occurred among 
the participants by reviewing the charting system for the days of fertility, the days of recorded 
intercourse, and the information on the pregnancy evaluation form.  Each couple that achieved a 
pregnancy was asked to confirm the pregnancy with a pregnancy test kit (i.e., the ClearBlue Easy 
One Minute Pregnancy Test) and self-evaluate the reason for the pregnancy with the online 
pregnancy evaluation form.  Each couple participant was asked to record their intention of either 
achieving or avoiding pregnancy and their level of motivation for avoiding a pregnancy, i.e., how 
hard they were trying to avoid pregnancy and how much they wanted to avoid it on a scale of 1-
10.   A determination was made if intercourse occurred during the fertile time as designated by 
the monitor and/or mucus fertility algorithms.  Each pregnancy was classified according to 
classifications recommended by Lamprecht and Trussell [20].   Pregnancies were classified as 
intentional only when they (the couple) indicated that they were using the given method to 
achieve pregnancy.  Pregnancies were classified as perfect use when the couple participant 
followed the instructions of the method and did not have intercourse during the estimated fertile 
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phase as determine by the algorithm of the given method.  Pregnancies were classified as user 
failure when couples had intercourse during the estimated fertile phase (as determined by the 
given method) and/or they did not follow the instructions of the method.  Perfect use (also 
known as method use) pregnancy rates were calculated using only perfect use menstrual cycles.  
Total pregnancy rates were determined by using both perfect use and user failure pregnancies 
and all menstrual cycles in the denominator of the equation.  
Acceptability and ease of use of the online FABM web site and fertility monitoring 
system was measured by asking the woman participant and her male partner at 1, 3, and 6 
months of use to respond to a 10-item questionnaire on whether the online web site was 
acceptable, easy to use, non-invasive, convenient in-home test of fertility, and provides clear and 
objective results.  The 10-item survey was a shortened form of an acceptability/ease of use 
questionnaire developed by Severy [21-23] for evaluating an EHFM. The 10 items are ranked on 
a scale from 1 to 7 and ranged in score from 10-70.  This is the same tool that was used in the 
prospective efficacy study of the EHFM plus CMM [13].  
  Information from participants was entered into a computer data set (by research 
assistants) in order to be analyzed with the Statistical Analysis System (SAS) and the Statistical 
Package for the Social Sciences (SPSS) software systems.  All statistical analyses were carried 
out using significance level alpha = 0.05.  To compare efficacy of the EHFM group with the 
CMM group, cumulative pregnancy rates were calculated by survival analysis with two different 
censoring variables: perfect use and total cycles.  Kaplan-Meier estimates were calculated for 
both the monitor and the mucus groups and the log rank test was used to determine if there was 
any significant difference in the survival functions of the two groups. In order to obtain an 
estimate of the hazard ratio and to test whether there was a significant difference in the two 
hazard functions, the proportional hazards regression model was used with the group variable as 
a covariate.  Changes across time and differences between the EHFM and the CMM group mean 
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scores of the acceptability survey were analyzed using a mixed model with repeated measures. If 
there was an indication of significant differences in certain fixed effects, Tukey's multiple 
comparison procedure was used to find where the differences lie. 
3. Results 
3.1. Participants 
  Of the 667 participants who enrolled in the online study, 89 were excluded from the study 
because they did not meet study criteria or they declined to participate (see Fig.1).  Examples of 
not meeting criteria include breastfeeding and living outside of the United States.  Five 
participants from the monitor group and 26 from the mucus group did not complete the initial 
quiz and therefore have been categorized as not having received the intervention of viewing the 
instructional video.  Lost to follow-up included the participants who never started charting or had 
incomplete charting and those that discontinued the intervention.  Reasons for discontinuation 
included seeking pregnancy, medical reasons such as endometriosis, polycystic ovarian 
syndrome, miscarriage, early menopause or surgery, in addition to personal reasons such as 
being too busy to chart and wanted to be assigned to the other group.  The menstrual cycles of 
participants who provided at least one complete cycle were included in the analysis.  The final 
number of participants in the monitor group was 197 and 160 in the mucus group.  
3.2. Demographics 
   The mean age, number of years married, number of living children, body mass index 
(BMI) and age of husband/partner were similar and there were no statistical differences between 
the two treatment groups (see Table 1).  In both groups, the greatest percentages of participants 
were Caucasian and Catholic. 
3.3. Efficacy 
  The perfect use and total unintended pregnancy rates of the two study groups are based 
upon 1,568 cycles of correct use (893 for the monitor group and 675 for the mucus group) and 
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2,621 total cycles of use (1,546 monitor and 1,075 mucus).  By intention of use, the total number 
of pregnancies for both groups was 32, with a 22.7 pregnancy rate for the monitor group and 
28.2 for the mucus group per 100 users over 12 months of use.  However, when the intended 
pregnancies were removed from the calculation, the perfect use pregnancy rate per 100 women 
over 12 months of use was 0 for the monitor group and 2.7 for the mucus group. There were no 
differences between the two groups in perfect use pregnancy rates. 
 As shown in Table 2, the total (unintended) pregnancy rate for the monitor group was 7, 
and 18.5 for the mucus group over 12 months of use.  In this case, both the survival and hazard 
functions of the monitor and mucus groups were significantly different. The rate of pregnancy in 
the mucus group is 2.96 times that of the monitor group (see Fig. 2). 
3.4. Acceptability 
 The EHFM and CMM groups showed no significant difference in the overall mean 
acceptability scores.  The survey total did demonstrate a significant change over time among 
both groups. Because the covariance matrix was compound symmetric, a Tukey post hoc test 
was used. The results showed a significant increase over time, i.e., the overall acceptability mean 
at one month was 55.5 (SD = 9.9) compared with 58.3 (SD = 10.7) at the sixth month of use 
(t(461) = 5.28, p < .0001) effect size = 0.02. 
3.5. Continuation rates 
  The continuation rates in use of the methods at 3, 6, 9, and 12 months by group are as 
follows:  for the monitor group, 82.2%, 64.5%, 52.3% and 40.6% at 12 months of use; for the 
mucus group, 66.4%, 50.6%, 45.1% and 36.6% at 12 months of use.  There was no statistical 
difference in the continuation rates between the two methods at 12 months of use.  
4. Discussion 
 The net correct use efficacy of both the EHFM and CMM group is very good, i.e., 98-
100% survival rate (or a 0 – 2 pregnancy rate per 100 women over 12 months of use) and 
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compares with what is found in the literature [24,25].   As hypothesized, the monitor group has 
better 12 month total pregnancy rate than the mucus group, i.e., 7 unintended pregnancies per 
100 women users among the monitor group versus 18 among the mucus group. The differences 
in pregnancy rates between the monitor and mucus group are similar to the differences that were 
found in a previous cohort comparison study of the monitor plus mucus versus mucus alone as 
two FABM [15].  The low unintended pregnancy rate (both perfect and total) are comparable to 
the pregnancy rates that were determined in a large European study that used mucus plus basal 
body temperature as a double check for the beginning and end of the fertile phase of the 
menstrual cycle [24] and with a pilot cohort study of the online FABM system conducted by the 
authors of this study, i.e., 9 unintended pregnancies per 100 among ovulating, non-breastfeeding 
participants [14]. 
 There are no studies to compare the efficacy of using the same EHFM (i.e., the CBFM) 
as was used in this current study to avoid pregnancy other than those conducted by the current 
researchers [12-16].  However, an earlier study reported the efficacy of a similar EHFM called 
the Persona fertility monitor [12,17,27].   Like the CBFM, the Persona monitor uses urinary E3G 
and LH as biological markers of fertility but instead of providing low, high, and peak fertility as 
feedback, it provides a green light (indicating infertility), a red light (indicating the fertile phase), 
and an orange light (indicating when testing begins).  The Persona’s method pregnancy rate was 
12.1 per 100 users [27].  After adjusting the E3G algorithm to provide a longer warning of the 
LH surge the annual pregnancy rate theoretically dropped to 6.  The authors of this study were 
criticized for using wrong methods in calculating pregnancy rates [28].  The Persona monitor is 
not approved for use in the US by the Food and Drug administration but is available in Europe 
and Canada.  The CBFM is readily available in the US for use as an aid to monitor fertility for 
the purpose of achieving pregnancy.  The pregnancy rates from the efficacy study of the Persona 
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[27] cannot be compared to the current study since we used different algorithms to estimate the 
fertile phase.           
 The total unintended pregnancy rates for the monitor group in the current study are better 
than those reported by Trussell for FABM [24,25], i.e., 7 for the monitor group compared to 25 
per 100 women by Trussell.  The mucus group with 18 unintended pregnancies per 100 is 
comparable but slightly better than what Trussell reports for the mucus-only OM.  The reason for 
the better rates for the current CMM might because of the double check with the use of a 
calendar based type method for determining the beginning and end of the fertile phase and by 
making the fertile phase automatically displayed in the online charting system.  Another reason 
for the differences in unintended pregnancy rates might be due to a relatively small, motivated 
and rather homogeneous number of participants.         
  Although there were no significant differences in acceptability between the monitor and 
mucus groups over time, there was a significant increase in acceptability and ease of use among 
all participants as they progressed through the study.  The increase in acceptability may be a 
result of the significant amount of participants dropping out of the study, i.e., those who felt it 
was not acceptable might have dropped out in the earlier phase of the study.  There was a similar 
continuation rate among both groups of participants. The increase in acceptability and 
satisfaction over time (for couples avoiding pregnancy) is not unusual for those learning and 
using FABM.  Researchers found similar results (i.e., increased satisfaction over time) with a 
cervical mucus-only method [29].  The acceptability rates found among the participants were 
similar to those in past studies that investigated the efficacy of the monitor plus mucus method of 
family planning [13,16].  So too, the drop-out rate of randomized comparison studies of FABM 
has a precedence in one of the few comparison studies of FABM in the United States [30].  This 
earlier randomized comparison study showed that a FABM combining basal body temperature 
monitoring with cervical mucus monitoring was more effective than a cervical mucus-only 
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method in helping couples avoid pregnancy.  However, the study had a 74% drop-out rate with 
the mucus-only method and a 64% with the combined method.  In comparison, the mucus group 
in the current study was 63.4% and for the monitor group 59.4%.  
 The biggest limitation of the present study is the loss of participants across the 12 
months of participation.  Of note, there were 125 participants who consented, were randomized 
and enrolled into the monitor group, were provided with a $200 monitor and then never provided 
any fertility charts.  It is probable that there was a sizable group that just wanted the free monitor.  
The study protocol included monthly attempts to encourage participants to provide data and 
reinforcing that they would receive $10 per fertility chart completed.  The most frequent reason 
for dropping out was “lost to follow-up,” then “no longer interested,” and “wishing to achieve 
pregnancy.”  A good portion of the participants who were randomized into the mucus group 
never participated; it is speculated that they were disappointed that they did not receive a free 
fertility monitor at the beginning of the study.  Some of the participants only enrolled into the 
study to receive a monitor and use it to achieve a pregnancy.  
 A strength of this study was that participants were from all regions of the United States.  
However, a limitation was that the participants were rather homogeneous, in that most were 
white, middle class, educated couples.  As such, the results of this study apply only to a similar 
group of educated and motivated participants.  An attempt was made to have a greater percentage 
of Hispanics by having the web site in the Spanish language and having access to Spanish-
speaking health professionals.  As pointed out, there was no difference in the demographic 
characteristics between the two groups of participants.   
  The findings of this study suggest that the use of an online system to enroll, randomize, 
and survey participants is an efficient way to conduct efficacy research for FABM.  The 
challenge is maintaining participation. A recommendation for future efficacy studies of FABM is 
to enroll only participants who are new to FABM.  There is a tendency of current users of 
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established FABM to compare their previous methods and to use them instead of the study 
method.  Future studies could use an online system to compare other established FABM such as 
the Standard Days Method or the Two Day Method, or even the older calendar-based formulas 
[31,32].   Another recommendation is to determine if use of hormonal fertility charting enhances 
the ability to achieve pregnancy among sub-fertile women.   
 A big challenge is to reach women and couples who do not have the financial means to 
be connected to the Internet and an online FABM system.   One way to help this might be to 
have online computer services available at convenient sites, like public libraries or health clinics.  
Another approach would be to have online charting available through cell phones and other 
hand-held devices.  Such a system could be linked to a FABM web site.  An inexpensive text-
based app system for inexpensive cell phones would be an ideal way to reach economically poor 
women who do not have access to the Internet and couples who wish to use FABM for religious, 
cultural, health, or personal reasons. 
5. Conclusion 
 The use of an online web-based fertility education, charting, and professional support 
system to teach FABM is very efficient and effective with correct use among highly motivated 
users.  Results indicate that the use of FABM in an online charting system is a more effective 
method of FABM (when used to avoid pregnancy) than the use of CMM.  There is a trend for 
greater satisfaction/ease of use for participants who use the online web site for tracking fertility 
and for use in family planning.   High drop-out rates and reaching a more diverse population of 
users interested in FABM is a challenge.  
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